drugset / Trial / NCT02520726

PTSD Prevention Study Examining the Efficacy of Sertraline in Burn Victims

NCT02520726

Phase 4 Terminated 5 enrolled University of Utah
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This is a randomized, double-blind, placebo-controlled study to determine whether administration of sertraline to patients who exhibit acute stress disorder secondary to severe burns can contribute to the prevention of post-traumatic stress disorder (PTSD).

Timeline

Start
2013-09
Primary completion
2016-09
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule 100 mg Oral
Subject Sertraline Small molecule 200 mg Oral